• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Special Reports
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Resources
    • About MassDevice
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
    • In-Depth Coverage
    • Latest News
  • Attend DeviceTalks
    • Events
      • DeviceTalks Minnesota – May 4
      • DeviceTalks Boston – May 27–28
      • DeviceTalks West
      • DeviceTalks Tuesdays
    • DeviceTalks Podcast Network
      • DeviceTalks Weekly
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Advertise
  • Subscribe
Home » FDA clears ROSA Shoulder robotic surgery system from Zimmer Biomet

FDA clears ROSA Shoulder robotic surgery system from Zimmer Biomet

February 22, 2024 By Sean Whooley

Zimmer Biomet Rosa Shoulder system
The ROSA Shoulder surgical robot system. [Image courtesy of Zimmer Biomet]
Zimmer Biomet (NYSE: ZBH) announced today that it received FDA 510(k) clearance for its ROSA Shoulder robotic-assisted surgery system.

The company says this marks the clearance of the world’s first robotic surgery system for shoulder replacement. It’s also the fourth application for the ROSA (Robotic Surgical Assistant) portfolio, which includes the ROSA Knee and ROSA Hip.

Zimmer Biomet said in a news release that ROSA Shoulder strengthens its shoulder implant portfolio. That includes the Identity Shoulder system and joins the ZBEdge Dynamic Intelligence platform. ZBEdge enhances the company’s digital technologies, robotics and implant solutions.

The company designed ROSA Shoulder to give surgeons the flexibility to execute total shoulder replacement using anatomic or reverse techniques. It enables precise placement for improved outcomes. According to Zimmer Biomet, it’s one of the only systems that can reproduce humeral head resectioning and ease insertion of instruments into incisions by requiring no pin in the center of the glenoid during procedures.

As with other ROSA applications, the system supports data-informed physician decision-making based on unique anatomies. It integrates with the newly released Signature ONE surgical planning system. Signature ONE uses a 3D image-based approach to visualization, surgical planning and patient-specific guide creation.

The company plans to launch ROSA Shoulder in the U.S. in the second half of 2024.

“We are proud and excited to be the first company in the world to deliver a robotic surgical assistant for anatomic and reverse shoulder replacement surgery,” said Ivan Tornos, Zimmer Biomet president and CEO. “ROSA Shoulder represents a novel advancement intended to help surgeons leverage the power of robotics and data analytics to perform highly complex shoulder procedures with accuracy1 and efficiency.”

Read next: 10 surgical robotics companies you need to know

Filed Under: 510(k), Featured, Food & Drug Administration (FDA), Health Technology, Orthopedic Implants, Orthopedics, Regulatory/Compliance, Robotic-Assisted, Surgical, Surgical Robotics Tagged With: Zimmer Biomet

More recent news

  • Boston Scientific continues to make progress on cyberattack recovery
  • Edwards Lifesciences, Medtronic score CMS win for TAVR
  • Stryker still working through cyberattack after-effects, stock down more than 10% this week
  • Siemens Healthineers completes $44M R&D, manufacturing site expansion
  • Next-gen Apple Watch Ultra 4 includes new health features

About Sean Whooley

Sean Whooley is a senior editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

Cart

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >
MDO ad
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2026 · Arrowfly LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly.

Privacy Policy